LONDON – Lululemon has backed a US$12m funding round for Epoch Biodesign as the biotech start-up-scales enzymatic recycling of nylon 6,6. The material is widely used in apparel, carpets, airbags and ropes. The round also included Extantia, Happiness Capital, KOMPAS VC and Leitmotif, taking Epoch’s total funding to more than US$50m.
This is Premium Content
Only user with Online and Print subscription can access this.
If you are a Free Subscriber, click here to upgrade.
If you already have Online or Print subscription Login To Unlock The Content!
